Acute Pulmonary Embolism Associated with Low-Dose Olanzapine in a Patient without Risk Factors for Venous Thromboembolism.
Vu Hoang VuNguyen Duong KhangMai Thanh ThaoMinh Khoi LePublished in: Case reports in vascular medicine (2021)
Olanzapine-associated pulmonary embolism is a rare entity and might be missed if the physician in charge is not vigilant and well informed. Even low-dose olanzapine can be associated with pulmonary embolism in patients with low classic risk factors if the treatment is prolonged. Pulmonary embolism should be sought in patients taking olanzapine even though the presenting manifestations are nonspecific.
Keyphrases
- pulmonary embolism
- low dose
- inferior vena cava
- venous thromboembolism
- risk factors
- end stage renal disease
- chemotherapy induced
- high dose
- case report
- ejection fraction
- newly diagnosed
- chronic kidney disease
- emergency department
- primary care
- liver failure
- peritoneal dialysis
- prognostic factors
- intensive care unit
- hepatitis b virus
- drug induced
- atrial fibrillation